Search Results - "M.G. Cusi"

Infection prevention in endoscopy practice: comparative evaluation of re-usable vs single-use endoscopic valves by Pasquale, L., Maurano, A., Cengia, G., Da Massa Carrara, P., Germanà, B., Graziani, M.G., Manes, G., Pisani, A., Golia, M., Marciano, E., Rodella, L., Schiffino, L., Gandolfo, C., Terrosi, C., Cusi, M.G.

“…Re-usable air/water and suction valves used in endoscopes often demonstrate risk of infection. To the authors' knowledge, the safety and efficacy of re-usable…”
Get full text

9135 POSTER Immune-modulating Effects of Bevacizumab and Metronomic Platinum Based-chemotherapy in Advanced Non-small-cell-lung Cancer (NSCLC) Patients by Bestoso, E, Botta, C, Apollinari, S, Giorgi, G, Cusi, M.G, Correale, P

Get full text

1418 POSTER Baseline Inflammatory Status Defined by Neutrophil to Lymphocyte Cell Count Ratio (NLR) Predicts Progression Free Survival (PFS) in Metastatic Colorectal Cancer Patients (mCRC) Undergoing Bevacizumab Based Biochemotherapy by Botta, C, Mazzanti, R, Cusi, M.G, Vincenzi, B, Mantovani, G, Licchetta, A, Tonini, G, Tassone, P, Tagliaferri, P, Correale, P

Get full text

1439 POSTER Treatment-related Changes in Systemic Inflammatory Status, Measured by Neutrophil-to-lymphocyte Ratio, is Predictive of Outcome in Metastatic Colorectal Cancer Patients by Botta, C, Mazzanti, R, Guglielmo, A, Cusi, M.G, Vincenzi, B, Mantovani, G, Tonini, G, Tassone, P, Tagliaferri, P, Correale, P

Get full text

6140 POSTER Cetuximab-mediated Immune-enhancing Effects in Vitro and in Metastatic Colorectal Cancer (mCRC) Patients by Correale, P, Botta, C, Cusi, M.G, Bestoso, E, Apollinari, S, Caraglia, M, Del Vecchio, M.T, Abbruzzese, A, Aquino, A, Tagliaferri, P

Get full text

Cetuximab ± chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro by Correale, P., Botta, C., Cusi, M.G., Del Vecchio, M.T., De Santi, M.M., Gori Savellini, G., Bestoso, E., Apollinari, S., Mannucci, S., Marra, M., Abbruzzese, A., Aquino, A., Turriziani, M., Bonmassar, L., Caraglia, M., Tagliaferri, P.

“…Cetuximab is a human/mouse chimeric IgG1 monoclonal antibody (mAb) to epidermal growth factor receptor, approved for colorectal carcinoma treatment in…”
Get full text

Thymidylate-synthase poly-epitope peptide vaccination in pretreated metastatic cancer patients; a multi-arm phase Ib trial by Correale, P., Botta, C.B., Martino, E.C., Gandolfo, C., Rossetti, M.G., Dreassi, E., Tassone, P., Tagliaferri, P., Pirtoli, L., Cusi, M.G.

Get full text

PRESENZA DI PAPILLOMAVIRUS AD ALTO RISCHIO ONCOGENICO IN UNA METASTASI DI UN CARCINOMA DELLA LARINGE by A. Giannattasio, P. Fierro, G. Panetti, R. Smeraglia, M.G. Cusi, G. Galano, C. Coppola

Get full text

Serum antibody response to respiratory syncytial virus F and N proteins in two populations at high risk of infection: Children and elderly by Sastre, P., Cusi, M.G., Manoha, C., Schildgen, O., Ruiz, T., Vela, C., Rueda, P.

“…Human respiratory syncytial virus (hRSV) is the main viral cause of severe respiratory infections in children and a common cause of morbidity in the elderly…”
Get full text

IDENTIFICAZIONE DEL PAPILLOMAVIRUS (HPV) DI TIPO 82 IN UNA LESIONE CLINICO-PATOLOGICA DELLA CERVICE UTERINA: NUOVO PROBABILE GENOTIPO AD ALTO RISCHIO PER IL CANCRO DELL’UTERO by A. Giannattasio, M.G. Cusi, C. Terrosi, A. Monzoni, V. Giuffrida, C. Avanzini, S. Selvaggini, G. D’Alessandro, F. Bartiromo, C. Lauterio, R. Santopietro, L. Pacenti, E. Falco, R. Smeraglia

Get full text

Development of a mouse model for the study of Toscana virus pathogenesis by Grazia Cusi, Maria, Gori Savellini, Gianni, Terrosi, Chiara, Di Genova, Giuseppa, Valassina, Marcello, Valentini, Melissa, Bartolommei, Sabrina, Miracco, Clelia

“…Toscana virus (TOSV) has recently been recognized as an emerging virus transmitted by phlebotomus vectors, responsible for acute neurological diseases in…”
Get full text

Influenza virosomes are an efficient delivery system for respiratory syncytial virus-F antigen inducing humoral and cell-mediated immunity by Cusi, M.G, Zurbriggen, R, Correale, P, Valassina, M, Terrosi, C, Pergola, L, Valensin, P.E, Glück, R

“…In the present study we investigated the efficacy of a new potential vaccine constituted of the respiratory syncytial virus (RSV)-F protein associated with…”
Get full text

Recruitment of dendritic cells and enhanced antigen-specific immune reactivity in cancer patients treated with hr-GM-CSF (Molgramostim) and hr-IL-2: results from a phase Ib clinical trial by Correale, P, Campoccia, G, Tsang, K.Y, Micheli, L, Cusi, M.G, Sabatino, M, Bruni, G, Sestini, S, Petrioli, R, Pozzessere, D, Marsili, S, Fanetti, G, Giorgi, G, Francini, G

“…Experimental findings suggest that granulocyte-monocyte-colony stimulating factor (GM-CSF) synergistically interacts with interleukin-2 (IL-2) in generating an…”
Get full text

Tumour-associated antigen (TAA)-specific cytotoxic T cell (CTL) response in vitro and in a mouse model, induced by TAA-plasmids delivered by influenza virosomes by Correale, P, Cusi, M.G, Sabatino, M, Micheli, L, Pozzessere, D, Nencini, C, Valensin, P.E, Petrioli, R, Giorgi, G, Zurbriggen, R, Gluck, R, Francini, G

“…We investigated influenza virosomes as a TAA-gene delivery system for use in TAA-directed anti-cancer vaccine therapy. An engineered plasmid (GC90) expressing…”
Get full text

Potential of DNA vaccines delivered by influenza virosomes by Cusi, M.G, Glück, R

Get full text

Immunopotentiating of mucosal and systemic antibody responses in mice by intranasal immunization with HLT-combined influenza virosomal vaccine by Cusi, M.G, Lomagistro, M.M, Valassina, M, Valensin, P.E, Glück, R

“…The mucosal vaccination strategy against influenza has been investigated by using influenza virosomal vaccine (IRIV) combined with two different adjuvants: the…”
Get full text

Recruitment of dendritic cells and enhanced antigen-specific immune reactivity in cancer patients treated with hr-GM-CSF (Molgramostim) and hr-IL-2 by Correale, P, Campoccia, G, Tsang, K.Y, Micheli, L, Cusi, M.G, Sabatino, M, Bruni, G, Sestini, S, Petrioli, R, Pozzessere, D, Marsili, S, Fanetti, G, Giorgi, G, Francini, G

Get full text

In Vitro Generation of Cytotoxic T Lymphocytes Against HLA-A2.1 -Restricted Peptides Derived from Human Thymidylate Synthase by Correale, P., Sabatino, M., Cusi, M.G., Micheli, L., Nencini, C., Pozzessere, D., Petrioli, R., Aquino, A., Vecchis, L. De, Turriziani, M., Prete, S.P., Sanguedolce, R., Rausa, L., Giorgi, G., Francini, G.

“…5-Fluorouracil (5-FU) is a pyrimidine antimetabolite active against colorectal carcinoma and other malignancies of the digestive tract. Over-expression or…”
Get full text

Detection by multiplex polymerase chain reaction and typing of Chlamydia trachomatis isolates by Valassina, M, Cusi, M G, Corsaro, D, Buffi, C, Piazzesi, G, Valensin, P E

“…The multiplex polymerase chain reaction (PCR) was applied for the detection of the Chlamydia trachomatis chromosome and plasmid. The multiplex PCR demonstrated…”
Get more information

Serological evidence of reinfection among vaccinees during rubella outbreak by Cusi, M G, Rossolini, G M, Valensin, P E, Cellesi, C, Zanchi, A

Get more information